Kaposi sarcoma ( Part 4 ) : Transplant associated kaposi sarcoma : USMLE Step 1
๐ ๐
๐จ๐ฅ๐ฅ๐จ๐ฐ ๐จ๐ง ๐๐ง๐ฌ๐ญ๐๐ ๐ซ๐๐ฆ:- https://www.instagram.com/drgbhanuprakash
๐๐๐ผ๐ถ๐ป ๐ข๐๐ฟ ๐ง๐ฒ๐น๐ฒ๐ด๐ฟ๐ฎ๐บ ๐๐ต๐ฎ๐ป๐ป๐ฒ๐น ๐๐ฒ๐ฟ๐ฒ:- https://t.me/bhanuprakashdr
๐๐ฆ๐๐ฏ๐๐ฐ๐ฟ๐ถ๐ฏ๐ฒ ๐ง๐ผ ๐ ๐ ๐ ๐ฎ๐ถ๐น๐ถ๐ป๐ด ๐๐ถ๐๐:- https://linktr.ee/DrGBhanuprakash
Transplant associated kaposi sarcoma
Occurs months to years after high dose immunosuppressive therapy; 0.2 - 1.0% of kidney transplants
Skin or metastatic lesions present
Skin lesions may regress if immunosuppression is stopped
Usually fatal if spreads to viscera
When KS develops in people whose immune systems have been suppressed after an organ transplant, it is called iatrogenic, or transplant-related KS. Most transplant patients need to take drugs to keep their immune system from rejecting (attacking) the new organ. But by weakening the bodyโs immune system, these drugs increase the chance that someone infected with KSHV (Kaposi sarcoma--associated herpesvirus) will develop KS. Stopping the immune-suppressing drugs or lowering their dose often makes KS lesions go away or get smaller.
#usmlevideos #usmlestep1 #uworld #kaposisarcoma #pathologyvideos #neetpgvideos #mbbs #pathovideos #patholectures #usmlestep1videos #usmlestep1lectures
-
Category
No comments found